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Breast cancer detection: radiologists’
performance using mammography
with and without automated whole-breast
ultrasound
Abstract
Objective Radiologist reader perform-
ance for breast cancer detection using
mammography plus automated
whole-breast ultrasound (AWBU)
was compared with mammography
alone. Methods Screenings for
non-palpable breast malignancies in
women with radiographically dense
breasts with contemporaneous
mammograms and AWBU were
reviewed by 12 radiologists blinded
to the diagnoses; half the studies were
abnormal. Readers ﬁrst reviewed the
102 mammograms. The American
College of Radiology (ACR)
Breast Imaging Reporting and Data
System (BIRADS) and Digital
Mammographic Imaging Screening
Trial (DMIST) likelihood ratings
were recorded with location
information for identiﬁed
abnormalities. Readers then reviewed
the mammograms and AWBU with
knowledge of previous
mammogram-only evaluation. We
compared reader performance across
screening techniques using absolute
callback, areas under the curve
(AUC), and ﬁgure of merit (FOM).
Results True positivity of cancer
detection increased 63%, with only a
4% decrease in true negativity.
Reader-averaged AUC was higher for
mammography plus AWBU com-
pared with mammography alone by
BIRADS (0.808 versus 0.701) and
likelihood scores (0.810 versus
0.703). Similarly, FOM was higher
for mammography plus AWBU
compared with mammography alone
by BIRADS (0.786 versus 0.613)
and likelihood scores (0.791 versus
0.614). Conclusion Adding AWBU to
mammography improved callback
rates, accuracy of breast cancer
detection, and conﬁdence in callbacks
for dense-breasted women.
Keywords Multi-readermulti-case
(MRMC)study . Diagnostic
accuracy . JAFROCanalysis . Breast
screening . Breastultrasound
Introduction
Screening with mammography has been shown to reduce
mortality from breast cancer [1, 2]. However, the
sensitivity to non-palpable cancer of screening mammog-
raphy in radiographically dense-breasted women is as low
as 30–48% [3]. Extremely dense-breasted women have an
18-fold increase in interval cancer found between annual
mammograms, compared with fatty-breasted women [4].
Magnetic resonance imaging (MRI) has been demon-
strated to be, and recommended as, an efﬁcacious adjunct
to mammography for very high-risk, dense-breasted
women [5, 6]. It has not been recommended for all
dense-breasted women. Three limitations to MRI screen-
ing for breast cancer are cost, intravenous injection of
gadolinium-containing contrast medium, and lower spe-
ciﬁcity of MRI compared with mammography [7] with
increased false positive callbacks and biopsies.
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ultrasound as an adjunct to screening mammography has
shown promise. Berg et al. increased cancer discovery 42%
by adding handheld whole-breast ultrasound performed by
radiologists [8]. Kelly et al. used an automated whole-breast
ultrasound (AWBU) device capturing a ciné loop of 2D
breast images [9]. This blinded study of mostly dense-
breastedwomenshoweda100%increaseincancerdetection,
and a 200% increase in discovery of invasive cancers 1 cmor
less, compared with mammograms alone. These ciné loops
were recorded and are available for reader trials similar to
those performed for comparison of screening mammography
with and without computer-aided detection (CAD) [10].
For AWBU to be a useful adjunct to screening
mammography for dense-breasted women, interpretation
of examinations must be shown as beneﬁcial, when
performed by community radiologists. This paper eval-
uates the performance of such radiologists in detection
before and after AWBU is added to a test set of screening
mammograms of radiographically dense-breasted women.
Materials and methods
Imaging studies
Mammograms Standard cranio-caudal (CC) and medio-
lateral oblique (MLO) views of each breast were
available for all cases. If implants were present,
displacement views were included. Original analog
ﬁlms (66 cases) or prints of digital ﬁlms (36 cases)
were used for review. All cases used in the study
provided informed consent, and the protocol was
approved by the Institutional Review Boards at each
hospital, or The Western Institutional Review Board [9].
AWBUs Automated whole-breast ultrasound (AWBU) is a
computer-based system for performing, recording, and
reading whole-breast ultrasound examinations similar in
appearance to 2D freehand imaging (SonoCine, Reno, NV).
Images were collected with 7- to 12-MHz multi-frequency
transducers. The transducerisattachedtoa computer-guided
mechanical arm that acquires images in CC rows over-
lapping 7 to 10 mm insuring complete coverage of both
breasts. Images are collected approximately 0.8 mm apart.
T h eA W B Us o f t w a r ec r e a t e sac i n él o o pf o rr e v i e wo f
approximately 3,000 images, simulating real-time imaging.
The Windows®-based reading station uses a high-deﬁnition
1,600×1,200 monitor and special software to increase
cancers’ conspicuity. The AWBU procedure was described
more fully in a previous publication [9].
Readers
Twelve board-certiﬁed breast radiologists who use breast
ultrasound in their practices were recruited as readers for
the trial. Remuneration for 3.5 days was at the prevailing
US rate. Eleven readers were from the USA and one from
Great Britain. Eleven had no experience with AWBU. One
had reviewed limited AWBUs 8 years earlier during the
developmental phase of the technology. No reader had
foreknowledge of the positivity rate of the test set.
Each reader had a 4-h tutorial with one author (KK)
explaining the AWBU reading station operation. The
readers reviewed and discussed approximately 12 AWBUs
with known cancers, not part of the test set. They were not
in the test set because either palpable ﬁndings were
present or there were no concurrent mammograms.
Nothing concerning the study was discussed, other than
the use of the data form (Appendix A) and the number of
cases to be reviewed.
Procedure
A set of 51 malignant cases (3 cases with bilateral
cancers), including invasive and in situ cancer were
collected for the trial (Table 1). Screening mammography
and AWBU were performed within 2 months of each
other. No cancers were associated with prospective
palpable ﬁndings or symptoms suggestive of cancer. The
mammograms were heterogeneously dense or extremely
dense breast tissue (BIRADS 3 or 4) on the original
reports. All imaging was performed from 2003 to 2008.
The data set included all cases meeting the above criteria
in the AWBU archives. Twelve cancers were included that
were not prospectively reported on either imaging techni-
que, but are visible in retrospect. Four of these became
palpable within 1 year, three in more than 1 year; ﬁve
were discovered in a subsequent screening round, three by
AWBU only, and two by both AWBU and mammography.
Fifty-one normal cases performed from 2003 to 2008
were matched with each of the positive cases for the
following factors:
1. Facility
2. Digital or analog mammogram
3. Ultrasound machine model
4. American breast cup size (A–DD)
5. ACR BIRADS breast density
6. Implant (saline or silicone) and location (pre- or
retropectoral)
7. Breast cancer history
8. Age
Table 1 Pathological diagnosis of 51 positive cases (54 cancers)
≤1c m > 1t o≤2 cm >2 cm Total
DCIS 2 0 4 6
IDC 17 19 5 41
ILC 3 2 1 6
Mixed IDC and ILC 0 1 0 1
Total 22 22 10 54
DCIS ductal carcinoma in situ, IDC invasive ductal carcinoma, ILC invasive
lobular carcinoma
2558The normal case matching factors 1 to 7 closest to the age
of the positive case was matched as the normal partner
case. The mean difference in age between the positive
case and its matched normal was 31 days.
Testing occurred on a subsequent date at each reader’s
own site with only the reader and a research assistant
(monitor) present. The same monitor was present for all
readers. She had no knowledge of the test set makeup, had
no mammography or ultrasound training, reviewed the test
data forms in real-time for completeness, and transferred
the data to the study database.
At each test site 102 mammograms were placed on a
ﬁlm alternator in random order, generated once, and used
for all readers. Excluding breaks, the test subject’s time for
review was recorded. The upper half of a data form
(Appendix A) was completed for each case, checked by
the monitor, and entered into the database.
Four questions were asked:
1. Would you request further evaluation based on this
mammogram, or recommend routine screening?
2. Where is/are the most suspicious (up to 3) lesions,
identifying their location by breast and clock face
position?
3. What would be your prediction of the ﬁnal ACR
BIRADS after any needed diagnostic workup was
completed?
4. Whatisthe reader’sc o n ﬁdencelevel thatthe womanhas
or does not have cancer (DMIST likelihood scale)?
The American College of Radiology Breast Imaging
Reporting and Data System (BIRADS) is a seven-point
scale (0 = incomplete, needs additional assessment; 1 =
normal; 2 = benign; 3 = probably benign; 4a = possible
malignancy; 4b = probable malignancy, or 5 = highly
suggestive of malignancy) designed to categorize the results
of mammography and other imaging studies [3, 11]. Scores
from1to5wereallowed.SimilartotheDMIST[12],readers
were askedtopredict a BIRADS scorebeforeanydiagnostic
workup.
The DMIST likelihood rating is a seven-point scale to
express the conﬁdence of the diagnosis, and ranges from
deﬁnitely not cancer to deﬁnitely cancer [3, 11, 12].
A correct location response was recorded for an hour
position marked within the half of the breast centered at
the middle of the cancer.
A true positive (TP) was recorded for mammography
for any malignant case if ‘callback’ was marked for
mammography and any correct tumor location was
identiﬁed. A TP was recorded for mammography plus
AWBU if ‘callback’ was marked on either or both halves
of the form in the malignant cases, with at least one
correct location identiﬁed. Thus, a correctly identiﬁed TP
found with mammography would remain TP even were it
not identiﬁed again on AWBU. AWBU ﬁndings could
change the outcome to TP if a cancer was correctly
identiﬁed with AWBU , but missed with mammography.
We evaluated readings on a per-case (i.e., per-patient)
basis rather than a per-score basis because screening
serves as a “go no-go” gatekeeper for subsequent workup
[13].
A true negative (TN) was recorded for mammography
for any normal case if ‘callback’ was not marked for
mammography. A TN was recorded for mammography
plus AWBU for any normal case if ‘callback’ was not
marked on the second half of the form. This allowed the
reader to reverse a callback for an asymmetric density
seen mammographically but cleared by the AWBU as no
suspicion. To validate TN cases, all cases were followed
for at least 1 year or more.
A false positive (FP) was recorded for mammography
in two situations:
1. Callback was marked for mammography in a normal
case.
2. Callback was marked for mammography in a cancer
case, but none of the marked locations corresponded
to the cancer.
An FP was recorded for mammography plus AWBU in
the same two situations as above when callback was
marked for AWBU. A false negative (FN) was recorded
for mammography when callback was not marked in a
cancer case in the mammography portion of the form.
Similarly, an FN was recorded for mammography plus
AWBU when callback was not marked in a cancer case in
either portion of the form.
The 102 ABWUs were reviewed by readers on a
review station brought by the research assistant acting as
a monitor. They worked approximately 8 h daily for
3 days, with breaks at the readers’ choosing. The
readers were given the corresponding mammograms
with each AWBU and completed the second half of
the data sheet with the knowledge from the mammo-
gram-only evaluation available. The same questions
were answered for AWBU and the reading time of each
AWBU recorded.
Statistical analysis
Analyses were conducted in a multi-reader multi-case
(MRMC) framework where each reader screened all cases
and each case contained both screening techniques. The
MRMC design efﬁciently reduces the number of readers
and cases needed to detect improvements across techni-
ques [14]. Analyses appropriate for an MRMC design
were chosen both to correctly model correlations between
readings on the same case across readers and to estimate
correctly standard errors. Unless speciﬁed otherwise,
analyses were conducted in SAS software version 9.2
(SAS Institute Inc., Cary, NC, USA). We present F
statistics, shown as F(numerator degrees of freedom,
denominator degrees of freedom), and p values for
comparisons between mammography plus AWBU and
mammography alone.
Cases identiﬁed for further imaging were assessed by
four binary measures: sensitivity = number of TP/number
2559of cancer cases; speciﬁcity = number of TN/number of
non-cancer cases; positive predictive value (PPV) =
number of cancer cases/(number of TP + FP cases); and
negative predictive value (NPV) = number of non-cancer
cases/(number of FN + TN). Random-effect logistic
regression models were used to test whether each binary
measure differed signiﬁcantly between mammography
plus AWBU versus mammography alone. To account for
the MRMC framework, we included random effects for
readers and cases similar to the DBM model [15].
Accuracy was assessed through BIRADS ratings and
DMIST likelihood scores, comparing two commonly used
indicators of accuracy between mammography plus
AWBU versus mammography alone: areas under the
curve (AUC) and ﬁgures of merit (FOM). The FOM
incorporates information from each reader on the region
of suspected malignancy, as well as their conﬁdence
level in the ﬁnding, incorporated in an AUC. Because it
includes both conﬁdence level and location accuracy, the
FOM is more powerful than AUC in detecting differ-
ences between techniques. We include both analyses, as
described below:
Areas under the curve (AUC) were estimated in DBM
MRMC2.1[15](availablefromhttp://perception.radiology.
uiowa.edu) using the trapezoidal/Wilcoxon method.
Readers and patients were treated as random factors. We
alsopresentreader-averagedreceiveroperatingcharacter-
istic (ROC) curves; average values were calculated from
separate ROC analyses conducted on each reader in the
PROC LOGISTIC procedure.
Figures of merit (FOM) were estimated by using
jackknife alternative free-response receiver operating
characteristic methodology as implemented in JAFROC
Version 1.0 [16] (available from http://www.devchakra
borty.com). The FOM is deﬁned as the probability that a
cancer on an abnormal image is scored higher than a
falsely marked location on a normal image and is
analogous to the ROC curve; a higher FOM indicates
improvement in reader performance.
Conﬁdence in identiﬁcation of cases for further imaging We
used linear regression, comparing BIRADS ratings and
DMIST likelihood scores across the two screening tech-
niques among TP cases; mean ratings and scores are
estimated by the regression for each screening technique.
To account for the MRMC framework, we included random
effects similar to the DBM model [15]; the model included
a ﬁxed effect for technique, classiﬁed as mammography
plus AWBU or mammography alone, and random effects
for readers and cases.
Table 2 Reader performance categorized by imaging technique (n=102, 51 positive cases)
Reader #
a True positives True negatives False positives False negatives
M M+A M M+A M M+A M M+A
1 2 84 53 22 12 73 01 56
2 2 84 52 52 13 33 01 66
3 2 54 43 02 03 23 11 57
4 2 64 32 02 84 32 31 38
5 2 64 33 23 02 82 11 68
6 3 24 32 03 74 31 47 8
7 2 64 12 52 73 32 41 81 0
8 2 34 03 53 11 72 02 71 1
9 1 64 04 32 52 12 62 21 1
10 27 39 34 36 27 15 14 12
11 26 37 35 41 24 10 17 14
12 22 37 37 34 20 17 23 14
Mean # of cases 25.4 41.4 30.7 29.3 29.0 21.8 16.9 9.6
% of 51 cases 49.8% 81.2% 60.2% 57.5% 56.9% 42.7% 33.1% 18.8%
Mean # of added cases 16.0 −1.4 −7.2 −7.3
Mean % of 51 cases added 31.4% −2.7% −14.1% −14.3%
% improvement compared with M alone 63% −4% −25% −43%
M mammography, M+A mammography plus automated whole-breast ultrasound (AWBU)
aReader # presented by best to worst performance based on sensitivity on M+A
Table 3 Reader performance with 45 invasive cases
≤1c m > 1t o≤2 cm >2 cm Total
#% # % # % #%
# of cancers 17 100 22 100 6 100 45 100
Mean cancers by mammography 4.4 26 13.5 61 3.0 50 20.9 46
Mean additional cancers by AWBU 6.7 39 6.6 30 2.0 33 15.3 34
Mean total cases detected 11.1 65 20.1 91 5.0 83 36.2 80
% improvement compared to mammography alone 151% 49% 67% 73%
For cases with more than one invasive tumor, the larger of the two was used. For interval cancers after imaging, size is the greatest diameter of the tumor seen
retrospectively on the AWBU or mammogram, otherwise the diameter is that reported by pathological diagnosis
2560Results
Sample Subjects averaged 59.4 years of age (SD = 10.2;
range = 41–83). The 51 cancer patients and 51 normal
subjects were well-matched with an insigniﬁcant mean
difference of 31.0 days in age between abnormal and
normal cases (t test=1.47, df=50, p=0.15). Table 1 lists
the types and size of cancers in the test set.
Identiﬁcation of cases for further imaging Table 2 details
individual performance in the identiﬁcation of cancer cases
for further imaging. Mean sensitivity increased from 50% to
81%, an improvement of 63% in the number of cancer cases
identiﬁed (25.4 vs. 41.4, F(1, 1,161)=165.95, p<0.001).
Speciﬁcity (60–58%; 30.7 vs. 29.1, F(1, 1,161)=1.11,
p=0.29), PPV (mean=47–67%; F(1, 1,297)=0.02, p=0.89),
and NPV (mean=65–75%; F(1, 933)=0.61, p=0.44) did
not change signiﬁcantly with the addition of AWBU.
Individual success varied from 11 to 24 more cancer
cases detected by AWBU. As a percentage of the cancers
detected with mammography the range in improvement
was 42–150%. Not only did all readers ﬁnd more cancers
individually, but all found 16–29% more cancers than the
best mammography reader did with mammography alone.
For the best performing mammography reader the cancer
detections added by AWBU was predictably lower, as
more cancers had already been identiﬁed with mammog-
raphy. For the poorest performer on mammography, the
addition of AWBU resulted in a 150% improvement,
bringing his overall cancer detection rate near the average
for the group.
Table 3 shows the average reader performance by
tumor size for the 45 image sets of patients with invasive
cancer. The greatest percentage increase was for cancers
1 cm and under. This is due largely to the relatively poor
performance at detecting these cancers with mammogra-
phy, where only 26% of cases were correctly identiﬁed.
By adding AWBU, the detection of these small cancers
was increased to 65%.
Accuracy The ROC area was greater for mammography
plus AWBU for both BIRADS (0.808 versus 0.701; F(1,
123) = 14.79, p<0.001) and likelihood scores (0.810
versus 0.703; F(1, 85) = 17.88, p<0.001) as estimated by
multi-reader multi-case analyses. This is highlighted in
Fig. 1 by ROC curves that are generated by averaging the
results of separate ROC analyses for each reader. The
BIRADS and likelihood AUC curves for mammography
and mammography plus AWBU in both cases almost
superimpose when conﬁdence in malignancy by mam-
mography is high, but when conﬁdence in malignancy by
mammography is low, as in the lower portions of the
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Fig. 1 Receiver operating
characteristic curves averaged
across 12 readers for
mammography alone (circles
and dashed line) and
mammography plus AWBU
(triangles and solid line)
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Fig. 2 Changes in areas
under the receiver operating
characteristic curve(s) for each
reader (hollow circles) and
averaged across 12 readers
(solid circles)
2561graphs, the curves in both cases diverge signiﬁcantly. In
both cases the mammography plus AWBU approaches the
y-axis indicating better cancer recognition.
Figure 2 shows the areas under the ROC curves for
each reader and for the average of all readers as estimated
by multi-reader multi-case analyses. These individual line
graphs mirror the improvement in reader performance
shown in Table 2.
Similar to ROC areas, the ﬁgures of merit (FOM) were
higher for mammography plus AWBU across all readers,
compared with mammography alone using both the
BIRADS scores (0.786 versus 0.613; F(1, 270)=34.1,
p<0.001) and DMIST likelihood scores (0.791 versus
0.614; F(1, 238) = 37.9, p<0.001) as accuracy indices.
Conﬁdence in identiﬁcation of cases for further imaging
Readers reviewing cancer cases were more conﬁdent in
correctly identifying cases for further imaging, i.e., TP
reading, using mammography plus AWBU compared with
mammography alone. On average, both BIRADS scores
(mean = 4.8 versus 4.2, F(1, 740) = 81.91, p<0.001) and
DMIST likelihood scores (mean = 4.8 versus 4.1, F(1,
740) = 82.21, p<0.001) were higher.
Interpretation times Average reading time per study for
the 102 AWBUs was 7 min 58 s (7:58) varying from 5:54
to 12:51. The difference in review time was unrelated to
the number of cancers identiﬁed by each reader (correla-
tion = 0.02, p=0.96).
Discussion
Signiﬁcant improvement in identiﬁcation of asymptomatic
cancers occurred for all readers in this study. This is shown
by a 63% increase in callbacks of cancer cases with only a
4% decrease in correct identiﬁcation of the true negative
cases. The conﬁdence of the diagnoses of the 102 cases
with predictive BIRADS and DMIST likelihood scales was
conﬁrmed by using AUC and FOM methodology.
With a short training period experienced radiologists
using 2D AWBU signiﬁcantly improve their ability to
diagnose cancer in dense-breasted women. This type of
AWBU is similar in appearance to real-time ultrasound
images. The slower transducer speed enforced by the
AWBU decreases inter-image distance, allowing the
reader more time to identify small masses. At a review
speed of 10 images per second the observer has 0.5 s to
identify a 5-mm mass. A high-resolution computer screen,
along with a post-processing technique to expand the
grayscale at the black end of the spectrum, results in
visually sharper margins and more contrast of masses
against the background tissue. These factors are designed
to make recognition of invasive cancers easier and more
reliable. This automated process for breast ultrasound
eliminates operator variability, provides greater consis-
tency, and ensures reproducibility of quality images. Study
radiologists increased discovery of T1a and T1b invasive
cancers 150% over mammography alone (Table 3).
The average review time per AWBU study was about
11 min shorter than the 19 min for radiologists in the
ACRIN 6666 trial of handheld screening ultrasound [8].
As half of our test set subjects had cancers, it would be
expected that the average review time we observed for
AWBU would be signiﬁcantly longer than in a typical
screening population with mostly normal studies.
Our study had a number of inherent weaknesses.
Although the test set was conﬁdential, the readers
probably quickly realized that it was enriched. They may
have been extraordinarily vigilant resulting in increases in
both TPs and FPs.
A false increase in TPs would occur if all the correctly
identiﬁed cancers were not subsequently conﬁrmed with
biopsy. Also, analysis was performed on a case basis in
the three patients in whom cancers were present in both
breasts; it was assumed if one of the cancers was
identiﬁed, the cancer in the other breast would be found
by the subsequent workup. This assumption might have
falsely raised the TPs and reduced the FNs . In addition,
we did not have a comparison with hand-held ultrasound.
Any of the following factors could have decreased the
readers’ accuracy with AWBU (decreased true positives
and negatives, and increased false positives and negatives)
compared with a normal screening situation.
1. Fatigue—Readers reviewed an average of 34 AWBUs
daily.
2. Inexperience with ultrasound screening—Some read-
ers do not perform screening ultrasound.
3. Limited experience with AWBU—This was the ﬁrst
exposure to AWBU for 11 of the readers.
4. Unfamiliarity with some ultrasound formats—Images
from many different manufacturers were used.
In spite of these hindrances our observations clearly
show that radiologists improve detection of cancers,
especially small invasive ones, by adding AWBU to
mammography ﬁndings.
Conclusion
This article demonstrates that experienced breast radiol-
ogists can learn to interpret 2D AWBU quickly.
Radiologists will signiﬁcantly improve their cancer
detection rates in dense-breasted women by adding
AWBU to mammography. This procedure has the
potential for both standardizing the performance of
whole-breast ultrasound and shortening the time required
for radiologists.
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